Ursodiol and Colorectal Cancer or Dysplasia Risk in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Meta-Analysis

Author： Hansen Jonathan   Kumar Sonal   Lo Wai-Kit   Poulsen David   Halai Umme-Aiman   Tater Kathy  

Publisher： Springer Publishing Company

ISSN： 0163-2116

Source： Digestive Diseases and Sciences, Vol.58, Iss.11, 2013-11, pp. : 3079-3087

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunosuppressive Agents for the Treatment of Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis

By  

Digestive Diseases, Vol. 35, Iss. 5, 2017-05 ,pp. : 478-485

Karger

Access to resources Recommend Favorite

Autoimmune pancreatitis and primary sclerosing cholangitis in a 16-year-old boy with inflammatory bowel disease

By Huelsen Alexander  

Clinical Journal of Gastroenterology, Vol. 5, Iss. 2, 2012-04 ,pp. : 131-135

Springer Publishing Company

Access to resources Recommend Favorite

Inflammatory Bowel Disease as a Risk Factor for Colorectal Cancer

By  

Digestive Diseases, Vol. 28, Iss. 4-5, 2010-11 ,pp. : 619-624

Karger

Access to resources Recommend Favorite

Colorectal Cancer in Patients with Inflammatory Bowel Disease: The True Impact of the Risk

By  

Digestive Diseases, Vol. 33, Iss. 1, 2014-12 ,pp. : 52-57

Karger

Access to resources Recommend Favorite

Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis

By Björnsson Einar   Cederborg Anna   Åkvist Anders   Simren Magnus   Stotzer Per-ove   Bjarnason Ingvar  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 9, 2005-09 ,pp. : 1090-1094

Informa Healthcare

Access to resources Recommend Favorite